20 August 2025
20 August 2025
As Novo Nordisk joins the US MASH market, Madrigal stretches Rezdiffra’s legs in the European market.
VK2735 met its primary endpoint but failed to outdo competitors Novo Nordisk and Eli Lilly in terms of body weight loss.
The FDA has requested that PTC run an additional study to prove vatiquinone’s efficacy prior to resubmission.
Direct-to-consumer platforms are expanding amid Trump’s pricing pressures, but uptake has hurdles.
āshibio will manage the global clinical development of vantictumab for both adult and paediatric patients.
NSCLC represents 80% of lung cancer cases and is the leading cause of cancer-related mortality globally.
Shares in the pharma company tumbled 9.5% amid the restructuring.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
